Chang JY, Lin SH, Dong W, Liao Z, et al. Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial. Lancet 2023 Jul 18:S0140-6736(23)01384-3. doi: 10.1016/S0140-6736(23)01384.
PMID: 37478883